A successful animal lab has just finished in Montreal Canada, performed by Dr. Ronald Denis. Dr. Denis is genuinely impressed by the stapling performance and advance concept of Into···
IntoCare Medical recently just finished the Series C Round Financing which is up to millions of RMB. Yuansheng Venture Capital led the investment, and former shareholder Qiming Venture Capital followed the i···
With a 3-month effort of all IntoCare members, IntoCare is very glad to share the good news with all friends and partners: Up till now all products in IntoCare™ Powered Stapling Platform are CE mar···
On March 25, when the COVID-19 is preliminary under control in China, on the other side of the continent, over one day Italy adds 5249 cases with a cumulative 69176 cases and Spain adds 2385 cases with a cum···
In China, before class III medical devices are being released to the market, clinical trials are required as a proof of effectiveness as well as safety.
Animal trials have always been one of the important methods to evaluate the effectiveness, safety and scientificity of medical devices. By studying the medical device performance on animals, experts can furt···
In the beautiful early autumn, Intocare flew across the continent from “Paradise on Earth”: Suzhou to “City of Music”: Vienna to attend the 14th Annual Meeting of European Society of Coloproctology.
IntoCare Powered Stapling Platform with E-Stapling Technology, offers an ergonomic, intuitive and uniformed stapling system resulting in a reduced learning curve for surgeons and simplified ease of use, and boosts confidence in consistent anastomotic integrity for a safer surgery.